JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greig, M. E.
Right arrow Articles by Gibbons, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greig, M. E.
Right arrow Articles by Gibbons, A. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 127, Issue 2, 110-115, 1959
Copyright © 1959 by American Society for Pharmacology and Experimental Therapeutics


THE EFFECT OF THREE TRYPTAMINE DERIVATIVES ON SEROTONIN METABOLISM IN VITRO AND IN VIVO

Margaret E. Greig 1, Robert A. Walk 1, and Anna J. Gibbons 1

1 Department of Pharmacology, The Upjohn Company, Kalamazoo, Michigan

agr- Methyltryptamine and agr-ethyltryptamine inhibited MAO activity both in vitro and in vivo. In vitro the activities of these indoles were of the same order as that of iproniazid. In vivo they differed from iproniazid in that their effect was reversible. 5-Hydroxy-agr-methyltryptamine was less active in vitro than the two other indoles tested and showed no inhibition in vivo in the dose used. agr-Methyl and agr-ethyltryptamine, but not 5-hydroxy-agr-methyltryptamine, caused an central stimulation of rats and mice. This effect correlated with the ability to inhibit MAO. agr-Methyltryptamine and 5-hydroxy-agr-methyltryptamine inhibited 5-hydroxytryptophan decarboxylase in vitro and in vivo as determined by Woolley's diarrhea test in mice. Although it is possible for agr-methyltryptamine to inhibit both MAO and 5-hydroxytryptophan decarboxylase in vivo the observed effects would indicate that MAO is predominantly affected.

Submitted on May 8, 1959







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1959 by the American Society for Pharmacology and Experimental Therapeutics.